Two cases of rare late onset life-threatening pseudoprogression with immune check point inhibitors in advanced cancer patients - a case report

Acta Oncol. 2021 May;60(5):683-686. doi: 10.1080/0284186X.2021.1885060. Epub 2021 Feb 13.

Authors

Valentin Coudert¹, Yves-Marie Robin^{2

3}, Williams Tessier⁴, Alexandra Forestier⁵, Nicolas Penel^{1

5}

Affiliations

¹ Medical School, Lille University, Lille, France.
² Biopathology Department, Centre Oscar Lambret, Lille, France.
³ Laboratoire « Protéomique, Réponse Inflammatoire et Spectrométrie de Masse » (PRISM), Inserm U1192, Lille University, Villeneuve d'Ascq, France.
⁴ Surgery Department, Centre Oscar Lambret, Lille, France.
⁵ Medical Oncology Department, Centre Oscar Lambret, Lille, France.

PMID: 33583310
DOI: 10.1080/0284186X.2021.1885060

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Aged
Disease Progression
Female
Humans
Immune Checkpoint Inhibitors* / therapeutic use
Male
Neoplasms* / drug therapy
Nivolumab

Substances

Immune Checkpoint Inhibitors
Nivolumab